HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2-bromo-5-(trifluoromethoxy)phenyl)thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway
HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2-bromo-5-(trifluoromethoxy)phenyl)thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway
复制标题
HMQ-T-F5 (1-(4-(2-氨基喹唑啉-7-基)苯基)-3-(2-溴-5-(三氟甲氧基)苯基)硫脲)通过抑制人宫颈HeLa细胞的增殖和迁移
DOI：
10.1016/j.phymed.2018.06.028
复制
发表时间：
2018-12-01
期刊：
影响因子：
7.9
通讯作者：
Zhang, Yanmin
中科院分区：
文献类型：
--
作者：
Dai, Bingling;Yang, Tianfeng;Zhang, Yanmin
Background: Drug therapy plays an important role in the treatment of cervical cancer, which is one of the most common solid tumors in women. Therefore, it is important to seek more effective and less toxic therapies.Purpose: The aim of this study is to investigate the therapeutic potential of HMQ-T-F5 (1-(4-(2-aminoquinazolin7- yl) phenyl)-3-(2-bromo-5-(trifluoromethoxy) phenyl) thiourea) (F5) for cervical cancer and explore the related mechanism.Methods: By performing MTT assay, colony formation assay, flow cytometry, wound-healing assay, transwell assay, immunofluorescent staining and siRNA assay, we study the effect of F5 on human cervical HeLa cells. The mechanism of F5 was also investigated.Results: We found that F5 significantly inhibited HeLa cell proliferation, led to accumulation of cells in the S phase, and induced apoptosis and inhibited migration. Mechanistically, F5 inhibited HeLa cell growth and migration through repressing the expression and nuclear translocation of beta-catenin, enhancing Axin expression, inhibiting the phosphorylation of LRP5/6 and GSK3 beta, as well as downregulating the Wnt downstream targeted proteins. Knockdown of a checkpoint beta-catenin by siRNA significantly attenuated HeLa cell proliferation. Furthermore, XAV939, an inhibitor of beta-catenin, was used to treat HeLa cells and the results demonstrated that F5 inhibited proliferation and migration via the inhibition of the Wnt/beta-catenin pathway.Conclusion: Our findings demonstrated that F5 can target beta-catenin potentially and is useful in the treatment of cervical cancer.
